Finding the silver lining
To mark World Cancer Day, Sandoz' Professor Michael Wiechmann outlines the impact of the pandemic on cancer patients
4th February 2021
Web Exclusives
Turning to Google
22% of Brits are buying OTC medicines online after self-diagnosing via the internet
3rd February 2021
Digital transformation in the CDMO market
By investing in new tech platforms CDMOs can dramatically increase efficiency in process development and manufacture of ever-more complex therapeutics
3rd February 2021
Is pharma passing the test on access to medicine?
COVID-19 threw pharma’s performance on access to medicine into the spotlight. Has the industry passed the test?
27th January 2021
Opportunities for health tech in 2021
Where we might see growth drive innovation in the healthcare industry amid COVID-19 and beyond
25th January 2021
A threat to innovation?
Could recent legal decisions on Supplementary Protection Certificates (SPCs) prove to be a hammer blow for the pharma industry?
14th January 2021
Progress in personalised renal dosing
Dose adjustment based on a patient's renal function is a very current example of personalising therapy. While this kind of precision medicine holds great potential, it is often overlooked, particularly in younger patients. Darcie Streetman and Rachel Eyler explore the growing knowledge and tools available for optimising renal dosing.
14th January 2021
Addressing inequalities in access to care
Improving standards of care nationwide with edge computing
6th January 2021
2020's legal hurdles for pharma
The year's legal decisions affecting the pharma industry
6th January 2021
Data breach
Legal implications of sensitive data falling victim to a cyber-attack within the healthcare industry
6th January 2021
Facebook diagnostics and the Amazon pharmacist
How tech-enabled patient autonomy can ease the healthcare burden
16th December 2020
Changes to IR35 legislation
The impending alterations to how pharma will engage with contractors may not be at the top of to do lists – but it should be, says Charlie Cox
16th December 2020
Is pharma putting all of its eggs in one COVID basket?
Siera Torontow considers pharma's success in dealing with ESG (Environmental, Social and Governance) issues and the impact on reputation
16th December 2020
Bridging the gap
A closer working relationship for pharma reps and healthcare professionals (HCPs)
16th December 2020
Partnering with patients
Partnerships to boost clinical research in rare diseases
16th December 2020
